Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
clinical trials
drugs
life sciences
national blog main
boston blog main
boston top stories
fda
patisiran
akcea therapeutics
alnylam pharmaceuticals
boston
inotersen
national top stories
new york blog main
new york top stories
onpattro
rna interference
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
tafamidis
acute hepatic porphyrias
akin akinc
aminolevulinic acid
anylam pharmaceuticals
barry greene
biotech
boston university
cannabidiol
cardiomyopathy
coronavirus
covid-19
dan ollendorf
dravet syndrome
epidiolex
fen-phen
fenfluramine
givosiran
gw pharmaceuticals
What
ago
5
×
fda
5
×
drug
medicine
alnylam
approved
patients
battle
pharmaceuticals
rare
rna
sets
weeks
akcea
amyloidosis
approval
approve
attr
authorization
available
awaits
bamlanivimab
biological
brand
called
cannabis
coronavirus
crossed
data
days
debilitating
decades
decision
derivative
developed
discovered
disease
eli
emergency
epilepsy
Language
unset
Current search:
ago
×
photo
×
fda
×
@bgr.com
3 years ago
This new drug will save lives until coronavirus vaccines are approved – here’s how it works
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug